Clinical Trials Directory

Trials / Unknown

UnknownNCT01646528

The Value of Black Spots in Diagnosing Gastric Intestinal Metaplasia by Confocal Laser Endomicroscopy

The Value of Mesenchymal Black Spots in Diagnosing Gastric Intestinal Metaplasia by Confocal Laser Endomicroscopy

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study aims to: 1. Explore the properties of mesenchymal black spots, and to determine the value of mesenchymal black spots in diagnosing gastric intestinal metaplasia by confocal laser endomicroscopy (CLE). 2. Evaluate the incidences of gastric intraepithelial neoplasia and gastric cancer in patients with gastric mesenchymal black spot during CLE imaging.

Detailed description

Gastric intestinal metaplasia (GIM) is confirmed to be a risk factor that may lead to the development of intestinal type gastric cancer. Previous study has shown that confocal laser endomicroscopy promising in the diagnosis of GIM. The investigators have found an elevated incidence of mesenchymal black spots in patients with GIM during previous CLE imaging. This study aims to explore the properties of mesenchymal black spots, and to determine the value of mesenchymal black spots in diagnosing gastric intestinal metaplasia by confocal laser endomicroscopy.

Conditions

Interventions

TypeNameDescription
PROCEDURECLE examination for upper gastrointestinal tractRoutine upper GI endoscopy plus targeted CLE examination

Timeline

Start date
2012-06-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2012-07-20
Last updated
2012-07-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01646528. Inclusion in this directory is not an endorsement.